(Q48793990)

English

Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

1 reference

based on heuristic

inferred from title

bipolar I disorder

1 reference

based on heuristic

inferred from title

5

object named as

Bo-Hyun Yoon

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

2

object named as

Won-Myong Bahk

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

1

object named as

Young Sup Woo

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

10

object named as

Kwang Heun Lee

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

Sang-Keun Chung

8

object named as

Sang-Keun Chung

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

7

object named as

Yong Min Ahn

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

9

object named as

Jeong-Gee Kim

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

author name string

Moon Yong Chung

3

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

Do-Hoon Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

Jong Hun Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

Ki-Chung Paik

11

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

publication date

2 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

Human Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

26

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

8

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

543-553

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

A rating scale for drug-induced akathisia

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Relapse and impairment in bipolar disorder

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Reversible elevation of triglycerides in dual-diagnosis patients taking aripiprazole: a case series

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

A rating scale for mania: reliability, validity and sensitivity

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Course and outcome in bipolar affective disorder: a longitudinal follow-up study

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

7 January 2021

based on heuristic

inferred from DOI database lookup

Twelve-month outcome after a first hospitalization for affective psychosis

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HUP.1240

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48793990&oldid=1835213656"